CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107. A total of 47 filers reported holding CARBYLAN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $35,000 | – | 9,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,178,941 | $4,268,000 | 0.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $1,303,000 | 0.19% |
| PURA VIDA INVESTMENTS, LLC | 80,000 | $290,000 | 0.12% |
| ALBION FINANCIAL GROUP /UT | 96,954 | $351,000 | 0.06% |
| ABNER HERRMAN & BROCK LLC | 31,182 | $113,000 | 0.06% |
| Opus Point Partners Management, LLC | 17,500 | $63,000 | 0.04% |
| WEDBUSH SECURITIES INC | 36,240 | $131,000 | 0.02% |
| MENTA CAPITAL LLC | 38,349 | $139,000 | 0.02% |
| Omega Advisors Inc. | 97,600 | $353,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 600,000 | $2,172,000 | 0.01% |